Form 4: AstroNova CFO Granted 87,260 Restricted Stock Units
Insider Transaction Report
AstroNova's Chief Financial Officer, Thomas D. DeByle, was granted 87,260 restricted stock units, which will vest in August 2028.
Summary
- Thomas D. DeByle, Chief Financial Officer of AstroNova, Inc. (ALOT), was granted 87,260 Restricted Stock Units (RSUs).
- Each restricted stock unit represents a contingent right to receive one share of ALOT common stock.
- The RSUs were granted on August 15, 2025, with a vesting and settlement date of August 15, 2028.
- Following this transaction, Mr. DeByle beneficially owns 87,260 derivative securities (RSUs).
- A Confirming Statement (Power of Attorney) dated April 30, 2025, authorizes specific individuals to file SEC reports on behalf of Thomas D. DeByle.
Sentiment
Score: 7
Explanation: The grant of restricted stock units to a key executive is generally viewed positively as it aligns management's long-term interests with shareholder value, promoting retention and performance. It is a standard compensation practice.
Positives
- The grant of restricted stock units aligns management's interests with shareholders, as the value of the RSUs is directly tied to the company's stock performance.
- This equity grant indicates continued commitment and long-term incentive for a key executive within the company.
Negatives
- There is no immediate cash inflow for the executive, as the value is realized only upon future vesting.
- The future conversion of RSUs into common stock could lead to minor share dilution, a standard aspect of equity compensation plans.
Risks
- The ultimate value of the restricted stock units is contingent on the future performance of AstroNova, Inc.'s common stock, exposing the executive to market fluctuations.
Future Outlook
The restricted stock units are scheduled to vest and settle on August 15, 2028, indicating a long-term incentive for the Chief Financial Officer and a commitment to future performance.
Industry Context
The grant of restricted stock units to a Chief Financial Officer is a common form of executive compensation in publicly traded companies, designed to align executive incentives with long-term shareholder value creation and promote retention.
Comparison to Industry Standards
- Granting restricted stock units (RSUs) as part of executive compensation is a widely adopted practice across various industries, including technology and specialized manufacturing sectors where AstroNova operates.
- This method is comparable to compensation structures at companies like Zebra Technologies (ZBRA) or Honeywell (HON), which frequently use equity awards to incentivize long-term performance and retention of key executives.
- The three-year vesting schedule for these RSUs is typical for such grants, aiming to retain talent and encourage sustained performance over a multi-year period.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorization for SEC Filings | A Confirming Statement (Power of Attorney) was filed, authorizing specific individuals to execute and file SEC Forms 3, 4, and 5, and other related reports on behalf of Thomas D. DeByle. | 04/30/2025 | This streamlines the process for insider reporting and ensures compliance with Section 16 of the Securities Exchange Act of 1934. |
Related Party Transactions
- Grant of 87,260 Restricted Stock Units to Thomas D. DeByle, the Chief Financial Officer, as part of his executive compensation.
Stakeholder Impact
- Shareholders: Potential future dilution upon vesting of the RSUs, but also improved alignment of executive incentives with long-term stock performance and value creation.
- Employees: Signals stability in leadership and adherence to standard executive compensation practices, which can positively influence morale and retention.
Next Steps
- The restricted stock units are scheduled to vest and settle on August 15, 2028, at which point they will convert into shares of AstroNova, Inc. common stock.
Key Dates
| Date | Description |
|---|---|
| 04/30/2025 | Date of the Confirming Statement (Power of Attorney) authorizing individuals to file SEC reports on behalf of Thomas D. DeByle. |
| 08/15/2025 | Transaction date for the grant of 87,260 Restricted Stock Units to Thomas D. DeByle. |
| 08/19/2025 | Date the Form 4 was signed and filed. |
| 08/15/2028 | Vesting and settlement date for the granted Restricted Stock Units. |
Keywords
AstroNova, ALOT, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Stock Grant, Thomas D. DeByle, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.